Patents by Inventor Chiung-Yin Huang

Chiung-Yin Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210106849
    Abstract: The present invention relates to a method for reducing an effective amount of Bevacizumab required for treating brain tumor. The present invention also provides a kit used for the aforesaid method. The present method adopts a combination strategy to combine Bevacizumab treatment with ultrasound exposure, which comprises at least the following steps: administering Bevacizumab to a subject; administering an ultrasound-response medium to said subject; and administering said subject with an ultrasound exposure. Specific effective amount of the Bevacizumab treatment and the ultrasound exposure were identified. The efficacy of conventional Bevacizumab treatment is significantly improved.
    Type: Application
    Filed: November 10, 2016
    Publication date: April 15, 2021
    Applicant: NaviFUS Co. Ltd.
    Inventors: Hao-Li LIU, Po-Chun CHU, Ting-Kuang CHANG, Kuo-Chen WEI, Pin-Yuan CHEN, Chiung-Yin HUANG
  • Patent number: 8992990
    Abstract: The present invention discloses a magnetic nanocomposite for inhibiting/treating cancer and a method for fabricating the same. The magnetic nanocomposite comprises a core formed of a plurality of magnetic nanoparticles made of ferric ferrous oxide (Fe3O4); a shell made of a carboxy-functionalized polyaniline; and an anti-tumor medicine bound to the external surface of the shell. The method of the present invention fast fabricates the magnetic nanocomposite in a simple way. The medicine of the present invention has a longer half life and a better thermal stability. The present invention disperses the water-insoluble medicine in water uniformly to decrease the biological rejection. Moreover, the magnetic nanocomposite of the present invention is guided to the nidus by an external magnetic field to increase the local concentration of the medicine and provide an effective chemotherapy. Therefore, the present invention has competitive advantage over the conventional BCNU.
    Type: Grant
    Filed: May 4, 2010
    Date of Patent: March 31, 2015
    Assignee: Chang Gung University
    Inventors: Mu-Yi Hua, Hung-Wei Yang, Rung-Ywan Tsai, Kuo-Chen Wei, Pin-Yuan Chen, Chiung-Yin Huang
  • Publication number: 20110104294
    Abstract: The present invention discloses a magnetic nanocomposite for inhibiting/treating cancer and a method for fabricating the same. The magnetic nanocomposite comprises a core formed of a plurality of magnetic nanoparticles made of ferric ferrous oxide (Fe3O4); a shell made of a carboxy-functionalized polyaniline; and an anti-tumor medicine bound to the external surface of the shell. The method of the present invention fast fabricates the magnetic nanocomposite in a simple way. The medicine of the present invention has a longer half life and a better thermal stability. The present invention disperses the water-insoluble medicine in water uniformly to decrease the biological rejection. Moreover, the magnetic nanocomposite of the present invention is guided to the nidus by an external magnetic field to increase the local concentration of the medicine and provide an effective chemotherapy. Therefore, the present invention has competitive advantage over the conventional BCNU.
    Type: Application
    Filed: May 4, 2010
    Publication date: May 5, 2011
    Inventors: Mu-Yi Hua, Hung-Wei Yang, Rung-Ywan Tsai, Kuo-Chen Wei, Pin-Yuan Chen, Chiung-Yin Huang
  • Patent number: D906344
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: December 29, 2020
    Assignee: FLYTECH TECHNOLOGY CO., LTD
    Inventors: Yun-Ping Liu, Chiung-Yin Huang
  • Patent number: D926251
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: July 27, 2021
    Assignee: FLYTECH TECHNOLOGY CO., LTD
    Inventors: Yun-Ping Liu, Chiung-Yin Huang